IP Library Granted Patent US 8,932,865
Granted Patent B2
US 8,932,865 · App. 13/809,223 · Granted Jan 13, 2015

Method for quantifying the amount of cholesterol in high-density lipoprotein 3

Inventors: Maiko Higuchi (Gosen, JP); Yasuki Itoh (Gosen, JP)
Assignee: Denka Seiken Co., Ltd.
G01N33/92C12Q1/60G01N2405/00C12Q1/44
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,932,865
App. No.
13/809,223
Granted
Jan 13, 2015
Kind
B2
Abstract

A method that enables quantification of cholesterol in high-density lipoprotein 3 (HDL3) in a test sample without requiring a laborious operation is disclosed. The method for quantifying cholesterol in HDL3 having: Step 1 wherein a surfactant that reacts with lipoproteins other than high-density lipoprotein 3 is reacted with a test sample to transfer cholesterol to the outside of the reaction system; and Step 2 in which cholesterol remaining in the reaction system is quantified. The method enables specific quantification of HDL3 cholesterol in a test sample using an automatic analyzer without requirement of a laborious operation such as ultracentrifugation or pretreatment. Further, quantification of the HDL2 cholesterol level can also be carried out by subtracting the HDL3 cholesterol level from the total HDL cholesterol level obtained by a conventional method for quantifying the total HDL cholesterol in a test sample.

Claims (15)

1. A method for quantifying cholesterol in high-density lipoprotein 3 (HDL3), said method comprising:

Step 1 reacting with a test sample in a reaction system, a surfactant(s) that react(s) with substantially all lipoproteins other than HDL3 to transfer cholesterol of the lipoproteins other than HDL3 to the outside of the reaction system; and

Step 2 wherein cholesterol remaining in the reaction system is quantified.

2. The method according to claim 1 , wherein said surfactant is at least one nonionic surfactant which is polyoxyethylene distyrene-modified phenyl ether.

3. The method according to claim 1 , wherein said surfactant is at least one nonionic surfactant selected from the group consisting of polyoxyethylene-polyoxypropylene condensates and polyoxyethylene-stearylamine, and/or anionic surfactant amide ether sulfate.

4. The method according to claim 1 , wherein said surfactant is at least one amphoteric surfactant selected from the group consisting of coconut oil fatty acid-amidopropyldimethyl-aminoacetic acid betaine, alkyl dimethyl-aminoacetic acid betaine and lauryl betaine.

5. The method according to claim 1 , wherein said surfactant is a cationic surfactant which is lauryl trimethyl ammonium chloride.

6. The method according to claim 1 , wherein said Step 2 is carried out in the presence of a surfactant(s) that react(s) at least HDL3.

7. The method according to claim 6 , wherein said surfactant used in Step 2 is at least one nonionic surfactant selected from the group consisting of polyoxyethylene lauryl ether and p-isooctyl polyoxyethylene phenol formaldehyde polymers.

8. The method according to claim 6 , wherein said surfactant used in Step 2 is amphoteric surfactant lauryl dimethyl-aminoacetic acid betaine and/or nonionic surfactant polyoxyethylene lauryl ether.

9. The method according to claim 6 , wherein said surfactant used in Step 2 is at least one anionic surfactant which is fatty acid series phosphoric acid ester.

10. The method according to claim 6 , wherein said surfactant used in Step 2 is at least one nonionic surfactant having an HLB of 11 to 14, selected from the group consisting of polyoxyethylene tribenzyl phenyl ether, polyoxyalkylene alkyl ether, polyoxyethylene polycyclic phenyl ether and polyoxyethylene cumyl phenyl ether.

11. The method according to claim 6 , wherein said surfactant used in Step 2 is at least one imidazoline-type amphoteric surfactant.

12. The method according to claim 6 , wherein said surfactant used in Step 2 is at least one type selected from the group consisting of polyoxyethylene lauryl ether, polyoxyethylene alkyl ether and polyoxyethylene alkyl phenyl ether.

13. The method according to claim 6 , wherein said surfactant used in Step 2 is nonionic surfactant lauryl alcohol alkoxylate and/or anionic surfactant sodium polyoxyethylene-alkyl phenyl ether sulfate.

Assignments (3)
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBERS 10007286 AND 10415007 PREVIOUSLY RECORDED AT REEL: 054513 FRAME: 0142. ASSIGNOR(S) HEREBY CONFIRMS THE MERGER. Recorded Dec 14, 2020
From: DENKA SEIKEN CO., LTD.
To: DENKA COMPANY LIMITED
Reel/Frame 055437/0045 →
MERGER Recorded Nov 24, 2020
From: DENKA SEIKEN CO., LTD.
To: DENKA COMPANY LIMITED
Reel/Frame 054513/0142 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 1, 2013
From: HIGUCHI, MAIKO; ITOH, YASUKI
To: DENKA SEIKEN CO., LTD.
Reel/Frame 029908/0063 →
Priority Claims (1)
JP 2010-166376 · Jul 23, 2010 · national
Continuity (1)
Related Publication 20130157374A1 · Jun 20, 2013